Status:

COMPLETED

Diabetes Interprofessional Team to Enhance Adherence to Medical Care

Lead Sponsor:

Thomas Jefferson University

Collaborating Sponsors:

University of the Sciences in Philadelphia

Conditions:

Diabetes

Eligibility:

All Genders

35+ years

Phase:

NA

Brief Summary

The overall goal of this randomized controlled trial is to test the efficacy of DM I-TEAM (Diabetes Interprofessional Team to Enhance Adherence to Medical Care) to reduce emergency department (ED) vis...

Detailed Description

AAs have twice the rate of DM as Whites, and worse glycemic control, less optimal medication regimens, and less trust in the medical system. These disparities contribute to why AAs with DM are more li...

Eligibility Criteria

Inclusion

  • African American race
  • Age ≥ 35 years; When first proposed the age criterion was 60 or older; it was later modified to 35 and older
  • Type 1 or 2 DM
  • A DM-related cause for the ED visit (i.e., hyperglycemia/hypoglycemia, diabetic ketoacidosis, chest pain, skin or soft tissue infection, diabetic neuropathy, retinopathy, urinary tract infection/pyelonephritis/acute renal injury, requesting DM medication refill) OR an hemoglobin A1c of 7.0% or greater within the past 30 days

Exclusion

  • Evidence of cognitive and functional decline suggestive of dementia.
  • Anti-dementia medication use
  • Life expectancy less than one year (in the opinion of the evaluating ED physician)
  • DSM-V psychiatric disorders other than anxiety or depression (as per EMR)
  • Intoxicated
  • Suicidal
  • In police custody or currently incarcerated
  • Undergoing medical clearance for a detox center or any involuntary court or magistrate order
  • Lives in assisted living, currently in a rehabilitation facility (other than Jefferson), lives in a nursing home or skilled nursing facility
  • Pregnant

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03393338

Start Date

January 1 2017

End Date

December 31 2021

Last Update

October 19 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107